STOCK TITAN

AMAZONAS FLORESTAL NEW - AZFL STOCK NEWS

Welcome to our dedicated page for AMAZONAS FLORESTAL NEW news (Ticker: AZFL), a resource for investors and traders seeking the latest updates and insights on AMAZONAS FLORESTAL NEW stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect AMAZONAS FLORESTAL NEW's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of AMAZONAS FLORESTAL NEW's position in the market.

Rhea-AI Summary

Amazonas Florestal, Ltd. (OTC: AZFL) has released its 2021 Annual Report, indicating significant revenue and profit growth, marking a historic milestone for the company. The report highlights a strong financial outlook as AZFL plans to launch various projects in Colombia, Mexico, and the USA in 2022. Notably, the company's subsidiary, Green America Laboratories, is progressing with approvals for a new facility in South Florida, expected to support product manufacturing. The management expresses optimism about achieving substantial growth and the possibility of tier upgrade to OTCQB or OTCQX later this year.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
-
Rhea-AI Summary

Amazonas Florestal, Ltd. (OTC:AZFL) announced that its subsidiary, Green America Laboratories (GAL), has submitted revised building plans to Miami-Dade County for approval. This submission is crucial for the development of a state-of-the-art extraction lab, set to become the first of its kind in South Florida, aiming to produce over 200 KGS/day of High-CBD T-Free distillates. Management anticipates operational commencement by Fall 2022, marking a significant milestone towards achieving positive revenues from U.S.-based operations and applying for QB or QX status.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.29%
Tags
none
-
Rhea-AI Summary

Amazonas Florestal, Ltd. (OTC: AZFL) announced significant business developments, including a recap of third-quarter financial results, revealing record revenues of $4.885 million and over $500k in gross profit. Their subsidiary, Green America Laboratories, is awaiting approval to build a state-of-the-art lab capable of producing 225 liters of CBD distillate daily. The company has expanded partnerships in Colombia and Mexico, projecting $30 million in sales for 2022. Additionally, AZFL is gearing up to introduce high CBD products across various international markets.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

Amazonas Florestal, Ltd. (OTC:AZFL) announced record 3rd quarter financial results, reporting consolidated revenues of $4.885 million with over $500k in gross income, the highest in company history. The company’s subsidiaries, Gamma Engineering and Innova Consulting Group, are thriving in the Colombian cannabis sector, with Innova projected to generate over $8 million in revenue for fiscal 2021. AZFL also completed a 51% acquisition of Colombia Dreams Marijuana, enhancing its competitive position in the market. Plans for a state-of-the-art lab in Miami are underway, expected to boost extraction capacity.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.11%
Tags
-
Rhea-AI Summary

Amazonas Florestal, Ltd. (OTC:AZFL) has signed a Memorandum of Understanding to acquire 51% of Colombia Dreams Marijuana (CDM), known for its cultivation and distribution of High-CBD Hemp and Medical Marijuana. CDM, based in Ciénaga, Magdalena, is fully licensed and specializes in high-quality cannabis genetics. CEO Ricardo Cortez highlighted Colombia's advantageous agricultural conditions that enhance the quality of cannabis. The formal acquisition agreement is set to be signed this week, solidifying AZFL's position in the cannabis market.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
5.88%
Tags
-
Rhea-AI Summary

Amazonas Florestal, Ltd. (OTC:AZFL) has released its Q3 financial report, reporting consolidated revenues of $4.885 million, the highest gross income of $502,483 in the company's history. The growth is attributed to its subsidiaries, Gamma Engineers and Innova Consulting, which are thriving in the cannabis sector in Colombia. Innova projects revenues exceeding $8 million for fiscal 2021. Additionally, the company is advancing plans for a state-of-the-art laboratory in South Florida, which is expected to become the largest hemp extraction facility in the region.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Summary

Amazonas Florestal, Ltd. (OTC: AZFL) has signed a memorandum of understanding (MOU) with Botánica de la Sierra, a licensed Colombian grower, to establish a new division focusing on high CBD and medical marijuana products. Botánica, which operates multiple cannabis licenses and farms, will help AZFL achieve vertical integration by developing manufacturing and lab facilities. With this partnership, AZFL aims to penetrate the Latin American and European markets as laws supporting medical marijuana usage evolve. The collaboration is expected to enhance their product offerings and distribution capabilities.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.53%
Tags
partnership
-
Rhea-AI Summary

Amazonas Florestal, Ltd. (OTC: AZFL) has formed a strategic alliance with Stilbon Corp, effective September 8, 2021. This partnership, formalized through a Memorandum of Understanding, will enable AZFL to distribute its hemp-derived products across three continents, beginning with over 3,000 points of sale in Italy. With the anticipated opening of AZFL's subsidiary, Green America Laboratories, in Q4 2021, Stilbon will assist in distributing its products to South America and the EU. Both companies expect to capture significant market share in the cannabis sector.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
11.76%
Tags
none
-
Rhea-AI Summary

Amazonas Florestal Ltd. (OTC: AZFL) announced its first positive revenues in over four years in its Q2 2021 Financial Statements, driven by consolidated operations from two new fully owned subsidiaries in Cali, Colombia. During a recent shareholder conference, management highlighted plans for a hemp extraction facility in South Florida, set to open this Fall, targeting emerging Latin American markets. The company aims to lead the cannabinoid extraction field and bolster operations in Mexico and Colombia.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.45%
Tags
none
Rhea-AI Summary

Amazonas Florestal (OTC:AZFL) has finalized its acquisition of Innova Consulting Group and Gamma Engineers & Consultants, strengthening its position in the cannabis industry. Innova, specializing in IT solutions for cannabis, achieved nearly $1M in sales last year with 30% net earnings. Gamma focuses on designing cultivation facilities for cannabis, expanding AZFL's capabilities. CEO Ricardo Cortez expressed confidence in these acquisitions for achieving a vertically integrated cannabis operation, targeting global growth.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
17.86%
Tags

FAQ

What is the current stock price of AMAZONAS FLORESTAL NEW (AZFL)?

The current stock price of AMAZONAS FLORESTAL NEW (AZFL) is $0.0001 as of April 16, 2024.

What is the market cap of AMAZONAS FLORESTAL NEW (AZFL)?

The market cap of AMAZONAS FLORESTAL NEW (AZFL) is approximately 1.6M.
AMAZONAS FLORESTAL NEW

OTC:AZFL

AZFL Rankings

AZFL Stock Data

1.64M
16.41B
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States of America
Miami